Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
12.90
-0.10 (-0.77%)
At close: Jun 05, 2025, 3:59 PM
12.89
-0.12%
After-hours: Jun 05, 2025, 04:04 PM EDT
-0.77% (1D)
| Bid | 10 |
| Market Cap | 186.81M |
| Revenue (ttm) | 200K |
| Net Income (ttm) | 1.72B |
| EPS (ttm) | 119.02 |
| PE Ratio (ttm) | 0.11 |
| Forward PE | -1.41 |
| Analyst | n/a |
| Ask | 14.24 |
| Volume | 40,602 |
| Avg. Volume (20D) | 110,079 |
| Open | 12.85 |
| Previous Close | 13.00 |
| Day's Range | 12.80 - 13.16 |
| 52-Week Range | 10.80 - 17.79 |
| Beta | -0.28 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
3 weeks ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...